tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CLNN Stock Latest News

Clene Announces Multi-Tranche Financing to Extend Cash Runway
Company AnnouncementsClene Announces Multi-Tranche Financing to Extend Cash Runway
2d ago
8K
CLNN
Clene Advances CNM-Au8 ALS Program with FDA Meeting
PremiumCompany Announcements
Clene Advances CNM-Au8 ALS Program with FDA Meeting
3d ago
8K
CLNN
Clene announces additional CNM-Au8 biomarker data for potential NDA filing
PremiumThe Fly
Clene announces additional CNM-Au8 biomarker data for potential NDA filing
3d ago
CLNN
Clene announces over $28M registered direct offering
PremiumThe Fly
Clene announces over $28M registered direct offering
6d ago
CLNN
Clene price target raised to $30 from $20 at Maxim
PremiumThe Fly
Clene price target raised to $30 from $20 at Maxim
1M ago
CLNN
Clene’s CNM-Au8 Shows Promise in ALS Treatment, Projecting Significant Stock Upside
PremiumRatingsClene’s CNM-Au8 Shows Promise in ALS Treatment, Projecting Significant Stock Upside
1M ago
CLNN
Clene Updates on CNM-Au8® ALS Program
Premium
Company Announcements
Clene Updates on CNM-Au8® ALS Program
1M ago
8K
CLNN
Clene Announces Positive Biomarker Results for CNM-Au8
Premium
Company Announcements
Clene Announces Positive Biomarker Results for CNM-Au8
1M ago
8K
CLNN
Clene announces significant reductions in NfL, GFAP when treated with CNM-Au8
PremiumThe Fly
Clene announces significant reductions in NfL, GFAP when treated with CNM-Au8
1M ago
CLNN
Clene Inc.: Promising Future with CNM-Au8 Advancements and Strategic Financial Management
PremiumRatings
Clene Inc.: Promising Future with CNM-Au8 Advancements and Strategic Financial Management
2M ago
CLNN
Clene Inc. Reports Continued Financial Losses in Q3 2025
PremiumCompany Announcements
Clene Inc. Reports Continued Financial Losses in Q3 2025
2M ago
CLNN
Clene reports Q3 EPS (85c), consensus (56c)
PremiumThe Fly
Clene reports Q3 EPS (85c), consensus (56c)
2M ago
CLNN
Clene sees cash runway into 2Q26
PremiumThe FlyClene sees cash runway into 2Q26
2M ago
CLNN
Buy Rating for Clene’s CNM-Au8 Driven by Promising ALS Treatment Potential and Market Interest
Premium
Ratings
Buy Rating for Clene’s CNM-Au8 Driven by Promising ALS Treatment Potential and Market Interest
2M ago
CLNN
Is CLNN a Buy, Before Earnings?
Premium
Pre-Earnings
Is CLNN a Buy, Before Earnings?
2M ago
CLNN
Clene’s CNM-Au8: A Promising Candidate in ALS Treatment with Buy Rating from Justin Walsh
PremiumRatings
Clene’s CNM-Au8: A Promising Candidate in ALS Treatment with Buy Rating from Justin Walsh
2M ago
CLNN
Clene’s CNM-Au8: A Promising Game-Changer in ALS Treatment with Buy Rating from Justin Walsh
PremiumRatings
Clene’s CNM-Au8: A Promising Game-Changer in ALS Treatment with Buy Rating from Justin Walsh
3M ago
CLNN
Clene Enters Equity Distribution Agreement with Canaccord
PremiumCompany Announcements
Clene Enters Equity Distribution Agreement with Canaccord
3M ago
8K
CLNN
Clene’s Promising Clinical Developments and Strategic Advancements Justify Buy Rating
PremiumRatings
Clene’s Promising Clinical Developments and Strategic Advancements Justify Buy Rating
4M ago
CLNN
Buy Rating for Clene Driven by Promising CNM-Au8 Developments and FDA Support
PremiumRatingsBuy Rating for Clene Driven by Promising CNM-Au8 Developments and FDA Support
4M ago
CLNN
Clene’s Promising Therapeutic Developments and Regulatory Progress Drive Buy Rating
Premium
Ratings
Clene’s Promising Therapeutic Developments and Regulatory Progress Drive Buy Rating
4M ago
CLNN
Clene Unveils Promising Clinical Data at ECTRIMS 2025
Premium
Company Announcements
Clene Unveils Promising Clinical Data at ECTRIMS 2025
4M ago
8K
CLNN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >